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Abstract
Background: Attention Deficit/Hyperactivity Disorder (ADHD), formerly regarded as a typical
childhood disorder, is now known as a developmental disorder persisting over the lifespan. Starting
in preschool-age, symptoms vary depending on the age group affected.
Method: According to the variability of ADHD-symptoms and the heterogeneity of comorbid
psychiatric disorders, a broad review of recent studies was performed. These findings were
summarized in a developmental psychopathological model, documenting relevant facts on a
timeline.
Results: Based on a genetic disposition and a neuropsychological deregulation, there is evidence
for factors which persist across the lifespan, change age-dependently, or show validity in a specific
developmental phase. Qualitative changes can be found for children in preschool-age and adults.
Conclusion: These differences have implications for clinical practice as they can be used for
prevention, diagnostic proceedings, and therapeutic intervention as well as for planning future
studies. The present article is a translated and modified version of the German article
"Entwicklungspsychopathologie der ADHS", published in Zeitschrift für Psychiatrie, Psychologie und
Psychotherapie, 56, 2008, S. 265-274.
Background
Formerly regarded as a typical disorder in childhood and
adolescence, Attention-Deficit/Hyperactivity-Disorder
(ADHD) is increasingly discussed as a serious psychiatric
disorder in adulthood [1-6]. Thereby ADHD shows high
heterogeneity and comorbidity with other psychiatric dis-
orders (e.g. Borderline Personality Disorder) [7-10].
Considering the developmental course of ADHD over the
lifespan, evidence exists that increasing age has an influ-
ence on the heterogeneity of ADHD-symptoms and asso-
ciated impairments. Regarding the fact that in many cases
hyperactivity is not primarily associated with the typical
deficits of adult ADHD, a developmental change is dis-
cussed [10]. Symptoms such as hyperactivity are not the
core symptoms in adulthood. Whereas children primarily
have problems in school, in adulthood different areas of
functioning are negatively affected (e.g. partnership,
work, social contact).
Today ADHD-specific-studies, instruments for psycholog-
ical assessment, and intervention programs are available
mainly for the treatment of children and adolescents.
However, in consideration of relevant publications in the
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last five years, there is strong evidence for the occurrence
of ADHD-related symptoms in preschool age and adult-
hood which has implications for the development of
assessment procedures and intervention programs [11-
13]. From a developmental psychopathological point of
view, the preschool age in particular is a matter of clinical
interest since early prognostic factors can alleviate a psy-
chological intervention and consequently prevent a path-
ological development [14].
ADHD - a lifespan disorder
Today ADHD is considered a multifactorial psychiatric
disorder, based on genetic predisposition and neurobio-
logical deregulation. These lead to a neuropsychological
inhibitory deficit which contributes to the specific impair-
ments typical for ADHD [15-18].
Genetics
There is strong evidence for a genetic disposition as a basis
for ADHD. Numerous twin-studies exist that indicate a
familiar interrelation [19]. Faraone et al. analyzed 20
extant twin-studies and estimated the mean heritability of
ADHD up to 76% [20]. Molecular genetic studies focus on
mutations in the DNA-sequences, which have a negative
influence on the proteins of the dopaminergic neurons
and lead to a dysfunction. Catecholaminergic genes, in
particular the dopamine receptor D4 (DRD4) gene, play
an important role. An association between frontal subcor-
tical networks and ADHD has been proven in different
studies [15,21]. Other genes discussed in connection with
ADHD are the dopamine receptor genes DRD5, DRD2,
DRD3, DRD1 as well as the dopamine transporter gene
DAT1 [17,19,22].
Neuroanatomy and neurobiology
In case of ADHD, the functional impairment of attention
performance is regarded as resulting from a dysfunction of
frontal-cortical-networks. Many symptoms in ADHD-
afflicted persons (e.g. deficits in focused attention, work-
ing memory, executive-functions) are comparable with
symptoms from patients suffering from frontal lobe dam-
age, which highlights the importance of the frontal corti-
cal networks [4,7]. Numerous studies demonstrated
complex processing mechanisms depending on a specific
attention dimension [23]. In case of deficits in inhibition
and visuospatial working memory, functional impair-
ments of the right inferior frontal gyrus can be observed in
lesion studies [24]. The activation seems to be influenced
by the noradrenergic system (locus coeruleus) and its pro-
jections in the right hemisphere. Furthermore, a regula-
tion of this process through the right prefrontal cortex is
assumed, which is supported by findings in related studies
that report a regional volume reduction [25]. Ströhle et al.
reported deficits of executive and motivational factors in
an fMRI-Study, using a paradigm of positive feedback and
removal of positive feedback. Deficits where seen in con-
sequence of a decreased activation in the ventral striatum
(expectation of positive feedback) and an increased acti-
vation in the orbito frontal cortex (answer on the type of
feedback). Thereby negative correlations between self-
described hyperactivity and impulsivity and the decreased
ventral striatal activation could be observed [26]. Regard-
ing the effect of ADHD on all brain regions, Castellanos et
al. performed a neuroimaging study, focusing on develop-
mental trajectories [27]. They found that activity in nearly
all brain regions was significantly decreased in children
and adolescents with ADHD (about 3%, adjusted). Inter-
estingly, the authors did not find evidence for primarily
frontal abnormalities as mentioned above. However,
based on a larger analysis of the different brain units, they
conclude that these findings cannot be regarded as evi-
dence against the interrelation between the ADHD symp-
tomatology and frontal-striatal networks. Focusing on the
fundamental developmental growth curve of the different
brain regions, the authors did not find different trajecto-
ries for ADHD affected children or adolescents and con-
trols. These findings implicate that no fundamental
developmental process can be observed, even if the
regional brain volumes of the ADHD-group are smaller
compared to controls.
Method
Regarding the developmental course ADHD seems to
become more unspecific in its psychopathological charac-
teristics over time, although it is based upon the same
neuropsychological dysfunctions as in childhood and
adolescence. This leads to two fundamental questions:
￿ During which part of the developmental pathway
can qualitative changes be observed?
￿ What are the reasons for these qualitative changes?
To answer both questions, a broad review of recent studies
(published between January 1997 and January 2009) was
performed. To this end, scientific databases (e.g. PubMed,
Sciencedirect, ISI Web of Knowledge, Springerlink) were
searched, using the keywords or keyword combinations of
*ADHD*, *prevalence*, *preschool*, *childhood*,
*adolescence*, *adulthood*, *lifespan*, *comorbidity*,
*developmental*, *genetic*, *neuropsychology*, *neu-
robiology*. Based on the evidence for a genetic/neurobio-
logical deregulation as the basis of the developmental
course of ADHD, studies highlighting preschool age,
school age/adolescence, and adulthood were selected. In
a first step, these findings were described under consider-
ation of actual prevalence rates and the specific develop-
mental course (e.g. frequent comorbid disorders and
resulting problems). In a second step, findings were sum-
marized in a developmental model and discussed regard-BMC Psychiatry 2009, 9:58 http://www.biomedcentral.com/1471-244X/9/58
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ing the above mentioned questions and the specific
phenomenology of each age group.
Results
ADHD in preschool children
Prevalence
Until now, only little representative international data on
the prevalence rate of ADHD in preschool children exist.
The results of the German Child- and Youth Health Survey
[28] can be mentioned as an exemplary study that investi-
gated prevalence rates on ADHD among N = 14.836 chil-
dren between the ages of 3 and 17 years. According to this
study, the prevalence rate among preschool children is
around 2%. Former studies in the US reported prevalence
rates up to 6% [29,30].
Developmental course
In this age group, ADHD symptoms are usually assessed
by means of rating scales and behavior observations [31].
Today a consensus is established as to how pathological
development differs from normal development. In a
Swedish study, 131 children between the ages of 3 and 7
and diagnosed with ADHD were compared to an age-
matched control group without ADHD [32]. Out of 12
symptoms assessed, the following were suitable to
describe ADHD in preschool children (ADHD-Rating
Scale-IV) [33]:
￿ problems with prolonged maintenance of attention,
￿ a high distractibility,
￿ being on the go often,
￿ excessive running/climbing,
￿ not adhering to instructions,
￿ having trouble to sit still.
It is necessary to state that in this age group already, a high
comorbidity with other behavioural disorders exists. In
the Preschool ADHD Treatment Study (PATS) Posner et
al. reported comorbid disorders in seventy percent of
ADHD cases, the most frequent being oppositional defi-
ant disorder (52.1%), communication disorders (24.7%)
and anxiety disorders (17,7%). These findings underline
the need for an early intervention and highlight the early
impact ADHD can have on the developmental course over
the lifespan [30].
ADHD among school children and adolescents
Prevalence
The prevalence rate of ADHD among school children and
adolescents diverges from 3.2% to 15.8%, depending on
the classification system used. Prevalence rates between
5% and 7% are reported most often [34,35]. Furthermore,
boys are two to four times more likely to be diagnosed
with ADHD than girls [36-38].
Developmental course
There are numerous different diagnostic instruments for
this age group. Questionaires and rating scales are based
on external sources (parents, teachers, educators) or self-
report, depending on the age group (usually from the age
of 11 onwards). For the neuropsychological assessment of
attention capacity, computer based instruments are used
in which attention regulation (stimulus inhibition, atten-
tion division, reaction flexibility) and attention load
(alertness, attention endurance, vigilance) are measured.
Untreated ADHD constitutes a high risk for a further neg-
ative development, which is especially due to frequent
comorbid disorders. During adolescence, ADHD can neg-
atively impair more and more areas of functioning
[39,40].
Among children with ADHD, in up to 65% of cases oppo-
sitional behavior is found [41] and among 23% of cases a
comorbid anxity disorder can be observed [42]. Further-
more, ADHD often co-occurs with school problems [43]
which, among other things, can be linked to comorbid
learning disorders such as dyscalculia [44]. Information of
teachers, parents and, from a certain age on, self-report
data reveal problems with peers, aggressive behavior and
diminished achievement motivation. With increasing age,
emotional problems increase, which in many cases result
from peer rejection, frequent hassles with teachers, as well
as the feeling „of being different“ [45]. Often children and
adolescents try to connect to peers who have similar prob-
lems which has a further negative impact on the child's/
adolescent's functioning (e.g. delinquency) [46]. Moreo-
ver, a relationship between risky traffic behavior and
ADHD was reported [47]. A very important problem is,
however, the issue of increased substance abuse. To
explain this link, a very complex causation model can be
presumed. The ADHD itself (reduced ability to suppress
stimuli, impulsivity), the influence of the social environ-
ment (peer group, family environment) as well as the
physical and cognitive appraisal of the consumption itself
(self medication) may play a role [48,49]. To determine
predictors for substance abuse, in the last 3 years alone
numerous prospective studies were conducted. For nico-
tine consumption of adolescents and adults with ADHD,
a relationship between behavior problems and subse-
quent tobacco consumption was reported [50]. In the fol-
low-up study of Burke and colleagues a predictive
relationship between inattentiveness and tobacco con-
sumption in youth as well as daily tobacco consumption
in adulthood was found [39]. A further prospective study
detected a strong association between the presence ofBMC Psychiatry 2009, 9:58 http://www.biomedcentral.com/1471-244X/9/58
Page 4 of 10
(page number not for citation purposes)
hyperactivity (at the age of 11 years) and the first con-
sumption of nicotine and other substances at the age of 14
[40]. For cannabis, a prospective birth cohort study (N =
1265; 0-25 age) found an association between early can-
nabis consumption and ADHD in adulthood, which was
moderated by the consumption of other substances [51].
It becomes apparent that the relation of ADHD and the
abuse of different substances play a determining role in
the transition to adulthood, which makes preventive steps
necessary.
ADHD in adulthood
Prevalence
For the transition to adulthood, studies document the per-
sistence of behavioural problems in 40-60% of the cases.
Prevalence rates between 1-7.3% were found [9,10,52-
54]. While in childhood salient gender differences exist, in
adulthood these cannot be found [55].
Developmental course
The developmental course is extremely heterogeneous,
which, among other things, results from the varied
comorbid disorders. Different studies report a strong rela-
tionship, particularly with substance abuse, affective dis-
orders, antisocial and borderline personality disorder. The
reasons for these overlaps are manifold and are related to
the similarity of the neurobiological processing mecha-
nisms of the different disorders (Table 1) [56].
Due to the comorbidity and deficits caused by ADHD,
other impairments often emerge which negatively influ-
ence the social and emotional well being of the affected
person. Difficulties in the organization of daily duties can
lead to problems at work, at home, and in social relation-
ships. Problems with emotion regulation can provoke
negative social interactions which further intensify the
psychological strain of the affected person and his/her rel-
atives and in turn heighten the risk of developing comor-
bid disorders. A negative spiral can be detected whose
severity differs depending on an individual's characteris-
tics and available resources. The following detailed
description of comorbid disorders will underline this.
Substance abuse
Prospective studies show an increased rate of substance
abuse [7,57]. In many cases a strong association was
found between the consumption of substances, behavior
disorders in childhood, and a negative social environment
[40,50]. Many patients report a better "drive" and ability
to concentrate when using stimulating substances. This
certainly has consequences for the diagnostic process;
first, it has to be clarified if the symptoms can be regarded
as reactions to the substance abuse rather than as ADHD
specific symptoms [51]. Furthermore, it should be
assessed which qualitative sensations result from the con-
sumption of different substances (in particular regarding
the reported improvement in attention processing).
Results of this assessment will also influence treatment
planning.
Depressive disorders
Emotional instability and emotional reactivity often occur
in adult ADHD. Many patients for example show extreme
reactions to frustrating events. Rapid mood changes with-
Table 1: Neurobiological correlates and overlap of symptoms with other psychiatric disorders [modified from 4].
disorder symptoms Involved neuroanatomic regions
Substance abuse Reduction of tension, enhancement of capacity to 
concentrate in certain situations, emotional 
stabilization
Striatum, dorsolateral prefrontal cortex, 
orbitofrontal cortex
Depressive disorders Problems with concentration, lack of drive, feelings 
of exhaustion, self doubts, social isolation, sleeping 
problems
Prefrontal cortex, anterior cingulate cortex, 
hippocampus, amygdala
Anxiety Disorders Self doubts, insecurity, phobic reactions, attention 
bias
Prefrontal cortex, anterior cinguler cortex, insular- 
and orbitofrontar cortex, amygdala, ventral striatum, 
grey layers
Anti social personality disorder Problems abiding to social norms, lower threshold 
for aggressive-violent behavior lack of adaptive 
problem solving strategies, low tolerance to 
frustration
Orbitofrontal cortex, ventromedial prefrontal 
cortex, limbic system
Borderline-personality disorder Disregulated emotional responsiveness, lack of 
adaptive problem solving strategies, affective 
instability, disorder of identity, instable but intensive 
relationships, inappropriate anger or problems to 
control anger
Orbitofrontal cortex, dorsolateral and ventromedial 
prefrontal cortex, amygdalaBMC Psychiatry 2009, 9:58 http://www.biomedcentral.com/1471-244X/9/58
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out apparent reason are also characteristic of the pathol-
ogy. In one study, a comorbidity of ADHD and major
depression was found in 15% of the cases [58]. Further-
more, 7.6% of the sample fulfilled the diagnostic criteria
of a dysthymic disorder and 10.4% of a bipolar affective
disorder. Hereby it has to be noted that especially the dis-
order mentioned last includes symptoms similar to those
of ADHD, which results in overlapping symptom criteria.
Other studies, that regarded ADHD as a risk factor for
developing a bipolar affective disorder, attained heteroge-
neous results. Wilens et al. state that, in their core ele-
ments, ADHD and bipolar affective disorders are clearly
distinguishable [59].
Anxiety disorders
Many ADHD affected persons have developed (dysfunc-
tional) strategies to avoid the confrontation with anxiety-
laden situations in order to manage their disorder. But
even though an unavoidable confrontation with individ-
ual anxiety-laden situations is assumed to have effect on
ADHD symptomatology, no causal direction between
ADHD and anxiety can be stated [60]. An overall
increased level of arousal as well as the tendency to hyper-
focus can facilitate the development of an anxiety disorder
[61,62]. Different studies about the comorbidity of
ADHD and anxiety disorders underline these findings.
Biederman reported a life time prevalence rate of comor-
bid anxiety disorders in 50% of the patients affected by
ADHD in adulthood [56].
Antisocial personality disorder/delinquency
The presence of oppositional behavior and, consequently,
the development of a conduct disorder elevate the risk of
developing an antisocial personality disorder [63]. In
adults with ADHD, these symptoms are often exhibited in
the form of aggressive traffic behavior, delinquency, and
as substance and alcohol abuse [64-66]. The domain of
delinquency in particular plays a significant role, with dif-
ferent studies highlighting the relation of ADHD, comor-
bid antisocial personality disorder and delinquent
behavior [25,67,68]. In their study on 129 male inmates,
Rösler et al. reported a 45% prevalence rate of ADHD,
according to the DSM-IV criteria. Hereby, the ADHD sub-
types [69] were distributed as follows: 21.7% of the com-
bined type, 21.7% of the predominantly hyperactive-
impulsive type and 1.6% of the predominantly inattentive
type. With the exception of the last type, all results were
significant compared to a control group. Regarding anti-
social personality disorder, the authors detected a preva-
lence rate of 9.3%, whereas among the control group, no
person suffered from an antisocial personality disorder.
This difference is not statistically significant, but rather
reflects a tendency. The strongest relationship between
ADHD and antisocial personality disorder was reported
for the group of inmates who exhibited conduct disorder
[66]. This is of special interest with regard to the frequent
comorbid disorders of ADHD in childhood and adoles-
cence [56]. It has to be stated, however, that prevalence
rates in numerous other international studies on the inter-
relation of ADHD and delinquency are lower [66-68].
Borderline personality disorder
The comorbidity of ADHD and borderline personality dis-
order can be regared as the biggest diagnostic challenge.
One reason is the substantial overlap of the diagnostic cri-
teria [9,10]. An association of ADHD in childhood and a
borderline personality disorder was found in a study of
Fossati and colleagues [70]. Among 42 patients with a
borderline personality disorder, 59.5% reported ADHD
symptoms in childhood. Miller, Nigg and Faraone like-
wise reported a clear link between ADHD and a border-
line personality disorder [71].
Discussion
Developmental model of ADHD
The above cited findings, in association with observations
and diagnostic findings from the clinical experience in the
treatment of persons affected by ADHD reveal age group
specific dysfunctions as well as persistent behavioral fac-
tors which result from the neurobiological basis of ADHD
(see figure 1). To clarify the aspect of a developmental
course across the lifespan, we developed a model. Even
though the model is confined in its complexity, it aims at
helping the reader to deduce hypotheses about age spe-
cific impairments caused by ADHD.
In the developmental model essential features are incor-
porated that
￿ heighten the risk to develop ADHD,
￿ persist along the life span,
￿ change along the life span, and
￿ are only valid in adulthood.
Multiple causal predisposing factors form the core of the
developmental psychopathology of ADHD. In the aetio-
pathogenesis of ADHD, the influence of genetic predis-
posing factors, [17,19] negative prenatal and socio-
environmental factors are regarded as certain. Different
prospective studies found a relationship between tobacco
consumption during pregnancy and ADHD in childhood
[72,73]. Besides a generally higher sensitivity to nicotine
consumption, the interaction between genetic vulnerabil-
ity and the smoking behavior of the mother during preg-
nancy is stressed for an ADHD subtype [74,75]. Other
toxins, such as alcohol or drugs, as well as stress are like-
wise seen as risk factors. However, results from different
studies reveal a contradictory picture.BMC Psychiatry 2009, 9:58 http://www.biomedcentral.com/1471-244X/9/58
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Across the lifespan, the occurrence of ADHD symptoms
first peaks during early elementary school age. In this
period, most of the ADHD diagnoses are given. Consider-
ing the developmental pathway (figure 1) it can be discov-
ered that, with increasing age, the symptom criteria and
comorbid disorders from preschool both persist and vary
due to the changing social environment of the child. In
the school context, skills are often affected which cause
deficits in academic performance. Students with ADHD
often perform less well compared to students without
ADHD [76]. In this context, the comparatively higher
comorbidity (compared to students without ADHD) with
other learning disabilities (reading or writing disabilities,
dyscalculia) must be mentioned [77]. Likewise, school
related anxieties can develop which can reach the symp-
tom severity of a phobic disorder [60]. Comorbid affective
disorders often emerge, with prevalence rates ranging
from 5 to 47% in childhood and adolescence [59,78]. On
the one hand these problems can be regarded as a conse-
quence of ADHD, on the other hand they occur due to
specific biological mechanisms, such as the linkage with
complex dompaminergic gating disturbances; the same
brain regions being affected in both disorders (ventral
striatum and nucleus accumbens, influenced by the hip-
pocampus and amygdala). Even though the interaction
between ADHD, anxiety-, and affective disorders can be
regarded as a developmental phenomenon, evidence
exists that the co-occurrence of anxiety disorders in chil-
dren with ADHD seems to increase their risk of develop-
ing depressive disorders [79]. As mentioned, it is
necessary to note that no causal direction between ADHD,
anxiety, and depressive disorders can be stated, but the
interrelation of these areas of psychosocial functioning
underlines the need for an early intervention [60]. With
increasing age, substance abuse and delinquent behavior
of individuals affected with ADHD increases [40,51].
At the transition into adulthood, involvement in traffic
offences increases. In a prospective study Fischer et al.
found a clear relationship between ADHD and rear end
collisions, tickets for ruthless driving, driving without a
driver's license, suspension of driver's license and driving
despite being suspended. Behavior observations while
driving revealed a higher incidence of mistakes, which can
be seen as a consequence of the impulsive behavior of
patients with ADHD. These findings are supported by the
Developmental psychopathological model of ADHD over the life span [modified from 13] Figure 1
Developmental psychopathological model of ADHD over the life span [modified from 13].
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results from a driving simulation in which a group of
ADHD patients showed slower reaction times with higher
variability compared to a control group [47]. Here too,
mistakes seemed to be due to their impulsive behavior
(e.g. through false reactions). This is in accord with the
neurobiological outcomes of various studies. Regarding
the developmental model, it can be assumed that along
the life span, basic deficits regarding neurotransmitter reg-
ulation persist for all age groups comparably. Age specific
changes in the disorder become apparent on the behavio-
ral level and are most obvious in adulthood. Regarding
the diagnostic criteria, a qualitative change in hyperactiv-
ity can be observed which is expressed as motor restless-
ness (e.g. restlessness of hand and feet or the continuous
"playing" with objects like a pen) and/or the experience of
„being driven“ (e.g. ADHD affected persons seem to be on
the go constantly and/or seem to feel nervous or uncom-
fortable). Until adulthood, comorbid disorders are sub-
ject to continuous development. The characteristics of
comorbid disorders, however, are based on the secondary
problems that manifested during childhood and adoles-
cence. Different comorbid disorders occur over the
lifespan, which is probably due to the changing require-
ments in adulthood leading to specific impairments in
individual areas of functioning (e.g. lower work perform-
ance in connection with disorganization). Special atten-
tion must be devoted to the already described comorbid
borderline personality disorder. The borderline personal-
ity disorder in its clinical presentation is very similar to
ADHD in adulthood. Studies showed that many affected
adults fulfill the criteria of ADHD in childhood. It seems
that ADHD in childhood is a risk factor for the develop-
ment of a borderline personality in adulthood [8,9,71]. A
possible relationship between antisocial personality dis-
order (APS) and ADHD is examined. Among 105 male
delinquents with a diagnosis of APS Semiz et al. found a
comorbid ADHD in 65% of the cases [80]. Lahey and col-
leagues detected that the combination of ADHD and a
comorbid behavior disorder in childhood can be regarded
as a predictor of APS in adulthood [81]. An isolated
ADHD, in contrast, did not predict APS in adulthood. It
seems that APS in adulthood is caused by a comorbid
behavior disorder that manifested itself along the life
span, rather than by the ADHD symptomatology. Com-
pared to ADHD in childhood, adults with ADHD are
impaired in different areas of functioning (social relation-
ships and partnership due to emotional over-responsive-
ness, affect instability; occupational area due to
disorganization).
Conclusion
In clinical practice, it is crucial to know during which
developmental stage qualitative changes in ADHD occur.
In accordance with the current state of knowledge, two
points in time seem likely. The preschool age seems to be
an important developmental stage in which ADHD symp-
toms can first be assessed. In many cases, early abnormal-
ities inhibit the full development of a child's resources.
The high comorbidity with other psychiatric disorders
(e.g. conduct disorder) and the resulting deficits in social
competences that often go along with a diminished qual-
ity of social contacts must be stressed. At this point in
time, preventive steps should be taken to counteract the
negative effects of ADHD.
The transition into adulthood can be regarded as a second
crucial developmental transition point. The assumption
that ADHD is a disorder that only occurs in childhood has
dominated clinical psychology for many years. Due to the
high comorbidity with other disorders, ADHD symptoms
are often overlooked; they do, however, seem to play an
important role in the manifestation of other comorbid
disorders. This complicates the diagnostic process because
symptoms of ADHD and comorbid disorders can overlap.
Affective disorders, as for example the borderline person-
ality disorder and the antisocial personality disorder, can
be mentioned here. For this reason and for the diagnostic
assessment in clinical practice, the developmental aspect
of ADHD is fundamental. Evidence for childhood ADHD
is a diagnostic criterion for ADHD in adulthood and
knowledge of the developmental course improves possi-
bilities for a comprehensive intervention.
To expand our knowledge one could ask a second ques-
tion, namely what causes the differences between symp-
tom manifestation of ADHD in childhood and
adulthood? According to neuropsychological findings,
the same neurobiological model underlies ADHD over
the whole life course. The symptomatological differences
between ADHD in childhood and adulthood seem to be
caused by environmental and social interaction factors. As
mentioned already, ADHD symptoms begin to occur dur-
ing preschool and elementary school age. These symp-
toms are more clearly circumscribed than is the case in
adulthood. Consequently, it can be assumed that over the
developmental course, on the one hand more areas of
functioning will be negatively affected by ADHD (which
is the case at the transition to adulthood), and on the
other hand a higher comorbidity can be found. Here
again, the relation with the secondary disorder becomes
apparent [63], which highlights the need for a preventive
and, if already manifested, early therapeutic intervention.
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